Entera Bio (NASDAQ:ENTX – Get Free Report) posted its quarterly earnings data on Friday. Entera Bio has a 12-month low of $0.91 and a 12-month high of $4.20. Get Entera Bio alerts:Institutional Trading of Entera BioLarge investors have recently added to or reduced their stakes in the business. Utilizing its proprietary oral delivery platform, Entera Bio seeks to overcome the challenges of gastrointestinal absorption for large peptide molecules. See AlsoReceive News & Ratings for Entera Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entera Bio and related companies with MarketBeat.com's FREE daily email newsletter.